Sign in: Staff/Students
In partnership with the University of Liverpool, Xi’an Jiaotong-Liverpool University (XJTLU) has launched its new Wisdom Lake Academy of Pharmacy.
The Academy, which plans to admit its first cohort of students in 2021, will feature three departments (Pharmaceutical Sciences, Pharmacy, and Biopharmaceuticals), and a number of undergraduate and postgraduate programmes. The Academy plans to have a total of 2,000 students by 2026, and will be initially based adjoining the Suzhou campus.
The key areas of research will be: novel therapeutic drug and strategy development, AI and pharmaceutics, and clinical pharmacy.
The institution will also feature several research centres, such as the Pharmaceutical Informatics and Data Science Institute, the Pharmaceutical Analysis and Testing Centre and the XJTLU-UoL Pharmacology Research Centre, among others.
Established in 2006 through a partnership between Xi’an Jiaotong University and the University of Liverpool, XJTLU has grown rapidly to become the largest international joint venture university in China, with the Academy of Pharmacy being the latest venture.
University of Liverpool’s Faculty of Health and Life Sciences, and the Department of Molecular and Clinical Pharmacology, will be cooperating with XJTLU in both teaching and research for the new Academy of Pharmacy at XJTLU, including development of a ‘talent pipeline’ of BSc, MSc and research leaders, engaging with industrial partners and practitioners to build an internationally leading relationship. The two Universities also plan to partner to establish the XJTLU Offshore Innovation Centre for Emerging Technologies (UK), which will leverage expertise from both institutions.
University of Liverpool Vice-Chancellor and Deputy Chair of Board of Directors of XJTLU, Professor Dame Janet Beer said: “Our history of excellence in teaching and research, and our current innovations in research into antimicrobials, infection research, cancer and Clinical Pharmacology, make Liverpool a specialist hub for drug research.”
“It is with excitement that we welcome XJTLU’s new Academy of Pharmacy to the University of Liverpool, and look forward to equally exciting collaborations and connections with such joint ventures as the XJTLU-University of Liverpool Pharmacy Research Centre & the SIP Bio-Medicine Offshore Innovation Centre in the UK. Drug research has never been more vital to the health and prosperity of our nations, and we warmly welcome these developments for our combined goals and likely accomplishments.”
Dr Yimin Ding, Vice President of XJTLU said: “XJTLU is in the ideal position to create this Academy for several reasons…firstly, we have amassed a large contingent of international staff, and with them, international experience and networks. Secondly, we are open and transparent, enabling strong partnerships with government and industry. Thirdly, we have built up a strong academic infrastructure over the years – we have sciences, engineering, arts, humanities and business, so we can enable multi-skilled students with a range of competencies.
“XJTLU’s philosophy is: if you want to do something, you need to make it unique. And that’s what we’re doing with the XJTLU Wisdom Lake Academy of Pharmacy.”
For more information on XLTLU please visit: https://www.liverpool.ac.uk/xjtlu/
All recent news
‘Moth motorways’ could help resist climate change impact
Free access to the Sports Centre, 23 May – 1 June
Making the most of library resources
Developing a next-generation therapy for knee osteoarthritis
Careers support for final year students and graduates
‘𝗠𝗼𝘁𝗵 𝗺𝗼𝘁𝗼𝗿𝘄𝗮𝘆𝘀’ 𝗰𝗼𝘂𝗹𝗱 𝗵𝗲𝗹𝗽 𝗿𝗲𝘀𝗶𝘀𝘁 𝗰𝗹𝗶𝗺𝗮𝘁𝗲 𝗰𝗵𝗮𝗻𝗴𝗲 𝗶𝗺𝗽𝗮𝗰𝘁.
New research by @LivUni @UniofReading @Rothamsted & @savebutterflies predicts the movement of British moth species in a changing climate.
Absolutely, @DivockOrigi is a Liverpool legend!
Teammate @JHenderson spoke about Origi's legacy at the club and also the city through his support of our @LivUni Divock Origi Scholarships (@LivEchonews): https://www.liverpoolecho.co.uk/sport/football/football-news/jordan-henderson-divock-origi-liverpool-24012741 https://twitter.com/LFC/status/1527592848345944066
"There has been nothing to point to Sars-Cov-2 being associated with this illness, far less being a cause. There is a stronger association with adenovirus and associated virus, which remain under investigation," says @LivUni_IVES Prof Calum Semple. https://www.telegraph.co.uk/news/2022/05/19/childrens-hepatitis-cases-have-peaked-doctors-study-genetic/